Pronation During Veno-venous Extra Corporeal Membrane Oxygenation

Sponsor
University Magna Graecia (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05198986
Collaborator
(none)
15
1
12.9
1.2

Study Details

Study Description

Brief Summary

The Acute Respiratory Distress Syndrome (ARDS) is defined by a recent (within 1 week) respiratory failure, not fully explained by cardiac failure or fluid overload. ARDS is also characterized by bilateral opacities at the chest imaging, with an alteration of the oxygenation while positive end-expiratory pressure equal or greater than 5 cmH2O is applied. Severe ARDS is characterized by a high mortality. In the most severe ARDS patients, venovenous extracorporeal membrane oxygenation (vv-ECMO) is increasingly accepted as a mean to support vital function, although not free from complications.

In patients with severe ARDS, prone position has been used for many years to improve oxygenation. In these patients, early application of prolonged (16 hours) prone-positioning sessions significantly decreased 28-day and 90-day mortality. More recently, prone position and ECMO have been coupled as concurrent treatment. Indeed, the addition of prone positioning therapy concurrently with ECMO can aid in optimizing alveolar recruitment, and reducing ventilator-induced lung injury. Nowadays, few data exist on respiratory mechanics modifications before and after the application of prone position in patients with severe ARDS receiving vv-ECMO. The investigators have therefore designed this observational study to assess the modifications of mechanical properties of the respiratory system, ventilation and aeration distribution, and hemodynamics occurring during ECMO before and after prone position in patients with severe ARDS.

Condition or Disease Intervention/Treatment Phase
  • Other: Prone Position during Extra Corporeal Membrane Oxygenation (ECMO)

Study Design

Study Type:
Observational
Anticipated Enrollment :
15 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Effects of Pronation on Respiratory System Mechanical Properties and Ventilation in Patients With Acute Respiratory Distress Syndrome During Vv-ecmo
Anticipated Study Start Date :
Feb 1, 2022
Anticipated Primary Completion Date :
Feb 28, 2023
Anticipated Study Completion Date :
Feb 28, 2023

Arms and Interventions

Arm Intervention/Treatment
ECMO Prone Position

After baseline assessment in supine position, patients will be positioned in prone position to assess modification of lung mechanics, aeration and hemodynamics

Other: Prone Position during Extra Corporeal Membrane Oxygenation (ECMO)
Pronation will be executed according to a predefined protocol: 4 caregivers will be required for the procedure, one of them being dedicated to the management of the head of the patient, the endotracheal tube and the ventilator lines. The others will stand at each side of the bed. In the first step, the direction of the rotation will be decided giving priority to the side of the central venous lines. The patient will be then moved along the horizontal plane to the opposite side of the bed selected for the direction of rotation. In the third step, the patient will be moved in the sagittal plane and maintained in that position for a short while to attach the cardiac electrodes to her/his back and to set a new bed sheet. In the last step, the patient will be turned to the complete prone position.

Outcome Measures

Primary Outcome Measures

  1. Driving Pressure [30 minutes after the prone positioning]

    Difference between the airway plateau pressure and the total positive end-expiratory pressure after an inspiratory and expiratory hold maneuvers, respectively

Secondary Outcome Measures

  1. Respiratory system compliance [30 minutes after the prone positioning]

    Driving pressure to the tidal volume ratio

  2. Cardiac output [30 minutes after the prone positioning]

    Liters of blood flow ejected from the heart per minute, measured through a pulmonary artery catheter

  3. Pulmonary arterial pressure [30 minutes after the prone positioning]

    pulmonary arterial pressure measured through a pulmonary artery catheter

  4. End-Expiratory Lung Impedance [30 minutes after the prone positioning]

    Measurement of the end expiratory lung volume, as assessed by the electrical impedance tomography

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • all adult patients with a diagnosis of severe Acute Respiratory Distress Syndrome receiving veno-venous ECMO
Exclusion Criteria:
  • mechanical ventilation for 7 days or longer

  • pregnancy

  • body mass index (BMI) > 45 kg/m2

  • chronic respiratory failure with long-term oxygen therapy or domiciliary non-invasive ventilation

  • cardiac failure resulting in veno-arterial ECMO

  • history of heparin- induced thrombocytopenia

  • cancer with a life expectancy of less than 5 years

  • moribund condition or a Simplified Acute Physiology Score (SAPS-II) value of more than 90;

  • current non drug- induced coma after cardiac arrest or presence of an irreversible neurologic injury

  • decision to withhold or withdraw life--sustaining therapies

  • presence of pneumothorax and/or pulmonary emphysema

  • recent (1 week) thoracic surgery

  • presence of chest burns

  • inclusion in other research protocols

  • refusal of consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Federico Longhini Catanzaro Italy 88100

Sponsors and Collaborators

  • University Magna Graecia

Investigators

  • Principal Investigator: Federico Longhini, MD, Magna graecia University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Federico Longhini, Prof, University Magna Graecia
ClinicalTrials.gov Identifier:
NCT05198986
Other Study ID Numbers:
  • ECMO-PP
First Posted:
Jan 20, 2022
Last Update Posted:
Jan 20, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Federico Longhini, Prof, University Magna Graecia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 20, 2022